These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 7776449)
21. [Status of surgery in the treatment of metastatic renal cell carcinoma]. Flamm J; Wöber L Wien Klin Wochenschr; 1987 Dec; 99(24):838-42. PubMed ID: 2449767 [TBL] [Abstract][Full Text] [Related]
23. [Individualized therapy with alpha-interferon in metastatic renal cell carcinoma]. Gross AJ; Dieckmann KP; Krain J; Huland H Urologe A; 1995 Mar; 34(2):158-61. PubMed ID: 7754588 [TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma. Fiori E; De Cesare A; Galati G; Bononi M; D'Andrea N; Barbarosos A; Izzo L; Bolognese A J Exp Clin Cancer Res; 2002 Jun; 21(2):229-32. PubMed ID: 12148583 [TBL] [Abstract][Full Text] [Related]
25. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate. Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227 [TBL] [Abstract][Full Text] [Related]
26. Laparoscopic cytoreductive nephrectomy: the M. D. Anderson Cancer Center experience. Matin SF; Madsen LT; Wood CG Urology; 2006 Sep; 68(3):528-32. PubMed ID: 16979706 [TBL] [Abstract][Full Text] [Related]
27. Extension of survival by resection of asynchronous renal cell carcinoma metastases to mediastinal lymph nodes. Whitson BA; Groth SS; Andrade RS; Garrett L; Dudek AZ; Jessurun J; Maddaus MA J Thorac Cardiovasc Surg; 2008 May; 135(5):1022-8. PubMed ID: 18455579 [TBL] [Abstract][Full Text] [Related]
28. [Late results of the complex treatment of primary kidney neoplasm in children]. Minkov N; Christosova I; Kiourktchieva S; Rousseva T Ann Urol (Paris); 1997; 31(6-7):344-7. PubMed ID: 9509234 [TBL] [Abstract][Full Text] [Related]
29. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz B; Belldegrun AS; Figlin RA Cancer; 2003 Jun; 97(12):2995-3002. PubMed ID: 12784334 [TBL] [Abstract][Full Text] [Related]
30. Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. Gettman MT; Boelter CW; Cheville JC; Zincke H; Bryant SC; Blute ML J Urol; 2003 Apr; 169(4):1282-6. PubMed ID: 12629343 [TBL] [Abstract][Full Text] [Related]
31. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma. Hafez KS; Novick AC; Campbell SC J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581 [TBL] [Abstract][Full Text] [Related]
32. Surgical care, morbidity, mortality and follow-up after nephrectomy for renal cancer with extension of tumor thrombus into the inferior vena cava: retrospective study since 1990s. Rigaud J; Hetet JF; Braud G; Battisti S; Le Normand L; Glemain P; Karam G; Bouchot O Eur Urol; 2006 Aug; 50(2):302-10. PubMed ID: 16759789 [TBL] [Abstract][Full Text] [Related]
33. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma. Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106 [TBL] [Abstract][Full Text] [Related]
34. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy. Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742 [TBL] [Abstract][Full Text] [Related]
35. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. Van Poppel H; Vandendriessche H; Boel K; Mertens V; Goethuys H; Haustermans K; Van Damme B; Baert L J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320 [TBL] [Abstract][Full Text] [Related]
36. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276 [TBL] [Abstract][Full Text] [Related]